[CYAN] Cyanotech Corporation

Overview

Type of security: Stock

Sector: Consumer Durables

Industry: Specialty Chemicals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 3.95 Change: 0.1 (2.6%)
Ext. hours: Change: 0 (0%)

chart CYAN

Refresh chart

Strongest Trends Summary For CYAN

CYAN is in the long-term down -23% in 1 year.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Cyanotech Corporation is engaged in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company?s products include Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids; and Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body?s natural inflammatory response, enhance skin, and support eye and joint health. Cyanotech Corporation sells its products in bulk quantities to manufacturers, formulators, and distributors in the health foods and nutritional supplements markets; and as packaged consumer products to distributors, retailers, and direct consumers. The company sells its products online and through resellers. Cyanotech Corporation was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 18.8% Sales Growth - Q/Q-0.01% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-0.08% ROE-0.11% ROI
Current Ratio2.73 Quick Ratio1.42 Long Term Debt/Equity0.68 Debt Ratio0.2
Gross Margin42.79% Operating Margin0.95% Net Profit Margin-0.07% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities90 K Cash From Investing Activities-3.42 M Cash From Operating Activities1.24 M Gross Profit2.87 M
Net Profit-100 K Operating Profit140 K Total Assets30.91 M Total Current Assets11.79 M
Total Current Liabilities4.32 M Total Debt5.34 M Total Liabilities9.43 M Total Revenue8.84 M
Technical Data
High 52 week5.63 Low 52 week3 Last close3.75 Last change2.18%
RSI88.17 Average true range0.16 Beta0.38 Volume11.19 K
Simple moving average 20 days15.5% Simple moving average 50 days16.61% Simple moving average 200 days4.53%
Performance Data
Performance Week20.97% Performance Month23.36% Performance Quart8.7% Performance Half5.63%
Performance Year-25.82% Performance Year-to-date24.17% Volatility daily3.05% Volatility weekly6.82%
Volatility monthly13.97% Volatility yearly48.39% Relative Volume200.28% Average Volume2.98 K
New High New Low

News

2019-02-27 10:57:07 | What Kind Of Share Price Volatility Should You Expect For Cyanotech Corporation NASDAQ:CYAN?

2019-02-13 08:00:00 | Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2019

2019-01-13 10:53:52 | Stocks That Fell to 3-Year Lows in the Week of Jan. 11

2019-01-09 08:00:00 | Cyanotech Names Brian Orlopp as VP Finance & Chief Financial Officer

2018-11-12 08:00:00 | Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal Year 2019

2018-09-07 13:00:00 | Cyanotech® Corporation Signs Asset Purchase Agreement for Cellana’s Kona Demonstration Facility

2018-08-13 08:00:00 | Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2019

2018-06-18 17:59:11 | Cyanotech reports $1M net income for fiscal year 2018

2018-06-15 08:00:00 | Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2018

2018-02-22 07:40:00 | Wired News – Aimmune Therapeutics’ Peanut Allergy Drug AR101 Met Primary Endpoint in Pivotal Phase-3 Clinical Trial

2018-02-06 08:30:00 | Cyanotech Reports Financial Results for the Third Quarter of Fiscal Year 2018

2018-02-05 08:49:14 | Are Cyanotech Corporation’s NASDAQ:CYAN Interest Costs Too High?

2018-01-24 08:30:00 | Cyanotech Names Mawae Morton as Chief Executive Officer and a Member of the Board of Directors

2018-01-23 14:43:21 | Should You Be Tempted To Sell Cyanotech Corporation NASDAQ:CYAN Because Of Its PE Ratio?

2017-12-25 09:38:08 | Cyanotech Corp. :CYAN-US: Earnings Analysis: Q2, 2018 By the Numbers : December 25, 2017

2017-11-21 13:19:08 | With An ROE Of 2.01%, Has Cyanotech Corporation’s CYAN Management Done A Good Job?

2017-11-06 08:00:00 | Cyanotech Reports Financial Results for the Second Quarter of Fiscal Year 2018

2017-09-29 09:04:47 | Cyanotech Corp. :CYAN-US: Earnings Analysis: Q1, 2018 By the Numbers : September 29, 2017

2017-08-10 08:00:00 | Cyanotech Reports Financial Results for First Quarter of Fiscal Year 2018

2017-08-07 08:00:00 | Cyanotech to Hold Investor Broadcast on Friday, August 11, 2017

2017-07-17 18:00:00 | Cyanotech Names Mawae Morton President

2017-07-17 08:30:00 | Cyanotech® Corporation Earns Halal Certification for BioAstin® Hawaiian Astaxanthin® Raw Material and Vegan Soft Gels

2017-07-10 07:40:00 | Featured Company News - Janssen Biotech Backs Out of Exclusive Licence Agreement for Development and Commercialization of Capricor's Lead Candidate CAP-1002

2017-06-26 12:53:15 | Cyanotech Corp. :CYAN-US: Earnings Analysis: Q4, 2017 By the Numbers : June 26, 2017

2017-06-22 08:00:00 | Cyanotech Reports Financial Results for Fourth Quarter and Fiscal Year 2017

2017-03-20 12:02:57 | Cyanotech Corp. :CYAN-US: Earnings Analysis: Q3, 2017 By the Numbers : March 20, 2017

2017-03-15 16:06:28 | CYANOTECH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic

2017-02-16 16:20:19 | CYANOTECH CORP Files SEC form 8-K, Other Events

2017-02-07 16:40:19 | CYANOTECH CORP Files SEC form 10-Q, Quarterly Report

2017-02-07 16:30:00 | Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2017

2016-12-19 06:05:38 | CYANOTECH CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders

2016-11-11 20:00:08 | Kailua-Kona-based Cyanotech reports second-quarter financials

2016-11-11 11:51:44 | Cyanotech Corp. :CYAN-US: Earnings Analysis: Q2, 2017 By the Numbers : November 11, 2016

2016-11-10 10:21:07 | Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal Year 2017

2016-11-10 09:00:49 | CYANOTECH CORP Files SEC form 10-Q, Quarterly Report

2016-11-10 08:00:00 | Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal Year 2017

2016-10-25 17:05:07 | Cyanotech Names Nancy Katz as a Director

2016-10-25 16:41:22 | CYANOTECH CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits

2016-10-25 16:30:00 | Cyanotech Names Nancy Katz as a Director

2016-09-22 09:30:00 | Cyanotech® Corporation Earns Non-GMO Project Verification for BULK SCE BioAstin® Natural Astaxanthin Products

2016-09-09 16:06:41 | CYANOTECH CORP Files SEC form 8-K, Other Events

2016-09-01 16:53:14 | CYANOTECH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligat

2016-08-29 06:05:55 | CYANOTECH CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders

2016-08-24 13:04:27 | CYANOTECH CORP Financials

2016-08-15 14:32:40 | CYANOTECH CORP Files SEC form 10-Q, Quarterly Report

2016-08-15 11:31:05 | Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2017

2016-08-15 08:00:00 | Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2017

2016-07-26 09:20:21 | Cyanotech Corp. :CYAN-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016

2016-06-30 09:53:40 | Cyanotech Corp. :CYAN-US: Earnings Analysis: Q4, 2016 By the Numbers : June 30, 2016

2016-06-23 16:23:57 | CYANOTECH CORP Files SEC form 10-K, Annual Report